Exploring Sleep Quality and Chronic Rhinosinusitis Risk Using Wearable Technology [0.03%]
利用可穿戴设备探索睡眠质量与慢性鼻窦炎风险的关系
Justina Varghese,Aakash Agarwal,Akshay R Prabhakar et al.
Justina Varghese et al.
Temperature-Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non-Inferiority Comparison With Surgical Intervention [0.03%]
温度控制射频消融治疗重度鼻腔阻塞的非劣效性研究与外科手术治疗方法比较
Greg Davis,Zeeshan Aziz,Jose Barrera et al.
Greg Davis et al.
Introduction: Temperature-controlled radiofrequency (TCRF), septoplasty (ST) with turbinate reduction, and functional rhinoplasty (FR) are treatment options for nasal airway obstruction (NAO) and nasal valve dysfunction (...
Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS [0.03%]
生物制剂治疗的以II型为主的慢性鼻窦炎患者手术范围与疾病控制之间的关系
Nicholas J Campion,Peta-Lee Sacks,Lu Hui Png et al.
Nicholas J Campion et al.
Background: A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the ...
On the Interpretation of Long-Term Outcomes After Combined FESS and Mepolizumab in Severe CRSwNP [0.03%]
内窥镜鼻窦手术联合美泊利单抗治疗严重CRSwNP的长期疗效分析
Francesca Pirola,Claire Hopkins
Francesca Pirola
Melissa Cummins,Ruifeng Cui,Ashley O&#x;Malley et al.
Melissa Cummins et al.
Air Quality Index Association With Cytokine Inflammatory Markers in Chronic Rhinosinusitis [0.03%]
慢性鼻窦炎患者空气质量和炎症细胞因子标志物的相关性研究
Nanda Nayak,Christina Dorismond,Rory Lubner et al.
Nanda Nayak et al.
Small Business Grants Awarded by the National Institutes of Health for Rhinologic Diseases, 1985-2024 [0.03%]
1985年至2024年美国国立卫生研究院授予的小企业补助金（涉及鼻窦疾病）
Jack Birkenbeuel,Mishek Thapa,Ericka L Erickson et al.
Jack Birkenbeuel et al.
Urinary Leukotriene E4 as a Biomarker of Disease Burden in Aspirin-Exacerbated Respiratory Disease: A Retrospective Cohort Study [0.03%]
白三烯E4尿检在水杨酸盐加重性呼吸道疾病中的应用：一项回顾队列研究
Alaa Alhalabi,Isaac Elijah,Bastien A Valencia et al.
Alaa Alhalabi et al.
Response to Probabilistic Sensitivity and Net Benefit Reporting in the Cost-Utility Comparison of EDS-Fluticasone Versus Budesonide Irrigation for Postoperative CRSwNP [0.03%]
有关EDS-氟替卡松与布地奈德冲洗液术后鼻窦炎伴鼻息肉治疗的成本效用比较的概率敏感性及净收益的回复信件
Daniel Xiao,Martin J Citardi,William C Yao et al.
Daniel Xiao et al.
Response to the Letter to the Editor by Pirola and Hopkins Regarding "the Global Airways in Practice: Long-Term Effects of Mepolizumab with or without FESS on Type 2 Inflammation in Patients with CRSwNP" [0.03%]
Pirola和Hopkins关于“实践中的全球气道：Mepolizumab联合或不联合FESS对CRSwNP患者第2型炎症的长期影响”的信的回复
Jens Tidemandsen,Vibeke Backer,Howraman Meteran et al.
Jens Tidemandsen et al.